Press release
Investigation announced for Long-Term Investors in shares of LifeMD, Inc. (NASDAQ: LFMD)
An investigation on behalf of current long term investors in LifeMD, Inc. (NASDAQ: LFMD) shares.
Investors who are current long term investors in LifeMD, Inc. (NASDAQ: LFMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: LFMD stocks follows a lawsuit filed against LifeMD, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: LFMD stocks, concerns whether certain LifeMD, directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that the defendants failed to disclose to investors that many of LifeMD’s executives were associated with Redwood Scientific when it was charged for unlawful autoshipping, abusive telemarketing, and false claims, and that they employed similar practices at the Company, that LifeMD engaged in autoshipping products to unwilling customers to record recurring revenue and the Company made it difficult to cancel such subscriptions, that certain of the purportedly licensed physicians on the Company’s platform were not in fact licensed and faced disciplinary action, that, as a result of the foregoing practices, the Company was reasonably likely to face regulatory scrutiny and/or reputational harm, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of LifeMD, Inc. (NASDAQ: LFMD) here
News-ID: 2340216 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for LifeMD
Telepsychiatry Market Size to Reach US$ 102.62 billion by 2033 - Exclusive Repor …
The global telepsychiatry market was valued at US$ 24.36 billion in 2024 and is projected to reach US$ 102.62 billion by 2033, growing at a CAGR of 16.6% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/telepsychiatry-market?sg
Mergers & Acquisitions in Telepsychiatry (2025):
✅ Teladoc Health Acquires UpLift: In April 2025, Teladoc Health, a leader in virtual care, acquired UpLift, a tech-enabled provider of mental…
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: …
An investor, who purchased shares of LifeMD, Inc. (NASDAQ: LFMD), filed a lawsuit over alleged violations of Federal Securities Laws by LifeMD, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and for certain investors are short and strict deadlines running. Deadline: October 27, 2025. NASDAQ: LFMD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Allergy Diagnostics Market on Track for Strong Growth, Estimated to Grow at 13.5 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Allergy Diagnostics Market Through 2025?
Over the past few years, the size of the allergy diagnostics market has witnessed rapid expansion. It is expected to increase from $6.32 billion in 2024 to $7.05 billion in 2025, representing a compound annual growth rate (CAGR) of 11.6%. Factors such…
Allergy Diagnostics Global Market to Observe Highest Growth of $10.4 Billion wit …
"The new report published by The Business Research Company, titled ""Allergy Diagnostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the allergy diagnostics market size has grown rapidly in recent years. It will grow from $5.77 billion in…
Allergy Diagnostics Market Size, Trends, Outlook By 2024-2033 |
The allergy diagnostics market size has grown rapidly in recent years. It will grow from $5.77 billion in 2023 to $6.48 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to rise in prevalence of allergies, investments in research and development of allergy diagnostics, changing dietary habits and environmental factors, government initiatives, rise in demand for…
Deadline on June 15th coming up in Lawsuit for Investors in LifeMD, Inc. (NASDAQ …
A deadline is coming up on June 15, 2021 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: June 15, 2021. NASDAQ: LFMD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
